Literature DB >> 22228148

Percutaneous fluoroscopically guided n-butyl cyanoacrylate (NBCA) injection for iatrogenic femoral arterial pseudoaneurysm under temporary balloon occlusion of arterial blood flow.

Motoki Nakai1, Morio Sato, Hiroki Sanda, Akira Ikoma, Nobuyuki Kawai, Hiroki Minamiguchi, Kouhei Nakata, Takami Tanaka, Tetsuo Sonomura.   

Abstract

PURPOSE: To evaluate the safety and efficacy of n-butyl cyanoacrylate (NBCA) injection under fluoroscopy for iatrogenic femoral artery pseudoaneurysms under temporary balloon occlusion.
MATERIALS AND METHODS: This treatment was approved by the Ethics Committee of our institute, and informed consent was obtained from the patients. Three male patients aged 82, 77, and 51 years developed femoral arterial pseudoaneurysms after catheterization. The pseudoaneurysms (diameter: 30, 12, and 15 mm; neck diameter: 1.8, 5.2, and 1.4 mm) were treated with percutaneous NBCA injection under fluoroscopy after failed ultrasound (US)-guided compression. First, a 4-Fr balloon catheter was inserted into the responsible femoral artery via the contralateral approach. An 18-gauge needle was placed in the pseudoaneurysm under US guidance, and a test injection of contrast medium was performed under fluoroscopic guidance to evaluate the extent of the pseudoaneurysm. NBCA-lipiodol (Lp) (ratio, 1:3) was then injected under balloon inflation. The balloon catheter was deflated and withdrawn after treatment.
RESULTS: The total volume of the injected NBCA-Lp was 0.4-1.5 ml. In each case, angiography immediately after NBCA-Lp injection showed eradication of the pseudoaneurysm, and color Doppler US revealed no blood flow signal. No complications were observed. Color Doppler US showed no recurrence in the three patients at their last follow-ups at 6, 12, and 12 months.
CONCLUSION: Percutaneous NBCA injection under fluoroscopy with the support of balloon inflation was safe, feasible, and useful for eradicating iatrogenic femoral artery pseudoaneurysms in three cases following failed US compression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228148     DOI: 10.1007/s11604-011-0049-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  17 in total

1.  Treatment of iatrogenic femoral pseudoaneurysms with percutaneous thrombin injection: experience in 54 patients.

Authors:  R G Sheiman; D P Brophy
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae.

Authors:  J K Song; Y P Gobin; G R Duckwiler; Y Murayama; J G Frazee; N A Martin; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Incidence of pseudoaneurysm after diagnostic and therapeutic angiography.

Authors:  R Katzenschlager; A Ugurluoglu; A Ahmadi; M Hülsmann; R Koppensteiner; E Larch; T Maca; E Minar; A Stümpflen; H Ehringer
Journal:  Radiology       Date:  1995-05       Impact factor: 11.105

4.  Treatment of iatrogenic femoral arterial pseudoaneurysms: comparison of US-guided thrombin injection with compression repair.

Authors:  E K Paulson; D H Sheafor; M A Kliewer; R C Nelson; L B Eisenberg; M W Sebastian; M H Sketch
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

5.  Treatment of a recurrent false aneurysm of the femoral artery by stent--graft placement from the brachial artery.

Authors:  Yuki Orimoto; Jasper W van Keulen; Evert J Waasdorp; Frans L Moll; Joost A van Herwaarden
Journal:  Ann Vasc Surg       Date:  2011-05-28       Impact factor: 1.466

6.  Percutaneous ultrasound-guided thrombin injection for the treatment of iatrogenic femoral artery pseudoaneurysms.

Authors:  Paraskevi A Vlachou; Christos D Karkos; Salena Bains; Mark J McCarthy; Guy Fishwick; Amman Bolia
Journal:  Eur J Radiol       Date:  2009-08-05       Impact factor: 3.528

7.  Low-dose thrombin injection to treat iatrogenic femoral artery pseudoaneurysms.

Authors:  S B Reeder; D M Widlus; M Lazinger
Journal:  AJR Am J Roentgenol       Date:  2001-09       Impact factor: 3.959

8.  Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients.

Authors:  R Zahn; S Thoma; E Fromm; R Lotter; M Zander; K Seidl; J Senges
Journal:  Cathet Cardiovasc Diagn       Date:  1997-01

9.  Ultrasound-guided compression repair for treatment of femoral artery pseudoaneurysm: acute and follow-up results.

Authors:  T Chatterjee; D D Do; U Kaufmann; F Mahler; B Meier
Journal:  Cathet Cardiovasc Diagn       Date:  1996-08

10.  The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injection.

Authors:  Juraj Madaric; Augustin Mistrik; Ivan Vulev; Branislav Liska; Matej Vozar; Peter Lederer; Martin Gocar; Terezia Kozlovska; Viliam Fridrich; Bernard De Bruyne; Jozef Bartunek
Journal:  EuroIntervention       Date:  2009-09       Impact factor: 6.534

View more
  4 in total

1.  Successful endovascular treatment of iatrogenic pseudoaneurysm with a relatively long neck.

Authors:  Masamichi Koganemaru; Toshi Abe; Naofumi Hayabuchi; Kanako Yokoi
Journal:  BMJ Case Rep       Date:  2013-01-18

2.  Novel Technique to Treat Common Femoral Artery Pseudoaneurysm using Angio-Seal Closure Device.

Authors:  Jon Robken; Nicolas W Shammas
Journal:  Int J Angiol       Date:  2014-07-04

3.  Type II endoleak model creation and intraoperative aneurysmal sac embolization with n-butyl cyanoacrylate-lipiodol-ethanol mixture (NLE) in swine.

Authors:  Motoki Nakai; Akira Ikoma; Romaric Loffroy; Marco Midulla; Atsufumi Kamisako; Nobuyuki Higashino; Kodai Fukuda; Tetsuo Sonomura
Journal:  Quant Imaging Med Surg       Date:  2018-10

4.  Ultrasound-guided thrombin injection in the management of pseudoaneurysm after percutaneous arterial access.

Authors:  Tomasz Jargiełło; Jan Sobstyl; Łukasz Światłowski; Maryla Kuczyńska; Ewa Kuklik; Michał Sojka; Anna Drelich-Zbroja; Maciej Pech; Maciej Powerski
Journal:  J Ultrason       Date:  2018
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.